Health & Medicine

A team of dermatologists and researchers at the Perelman School of Medicine has found a way to directly target neutrophils, a type of immune cell implicated in Sweet’s syndrome, with the potential for treating the disease without steroids.

In Lancaster County, ChildProtect community clinics have provided free vaccines against preventable diseases for 30 years—with an added dose of trust.

A new report from the National Academies of Science, Engineering, and Medicine outlines a roadmap to strengthen breastfeeding support through national coordination, public health programs and health care strategies, coverage of lactation services and supplies, and workplace supports. Penn Nursing’s Diane L. Spatz served as one of 15 national experts on this study.

Early research from Penn Medicine finds a new mRNA vaccine stops allergens from causing immune reactions and life-threatening inflammation, with promise for future treatment for a variety of seasonal and food allergies.

A new Penn Nursing study suggests that the weight-loss drug tirzepatide may cause fewer side effects like nausea and vomiting than the drug semaglutide. The research, published in Science Advances, was conducted using preclinical models to study the effects of the drugs.

Nearly 70 students from Penn Nursing and Penn Engineering participated in the Datathon, sponsored by the Penn Community Collaboratory for Co-Creation last month, using the MIMIC-IV database, a massive critical care dataset, to develop innovative, data-driven solutions for real-world health care challenges. Team 6 CARE: A Critical-care Acuity & Resource Evaluation Metric earned the top award by creating a solution to better evaluate patient acuity and resource needs.

Kathryn Connell, assistant professor in the Department of Biobehavioral Health Sciences at Penn’s School of Nursing, has been named a Fellow of the American College of Critical Care Medicine. Connell is a critical care nurse and health services researcher dedicated to improving outcomes for both patients and clinicians in intensive care units.

When Zoey the cockapoo developed a fear of the dark, her owner, Adam Weitz, sought a veterinary ophthalmologist. The grim news was that Zoey had progressive retinal atrophy (PRA), a category of genetic, blindness-causing diseases that have no cure. Zoey would be totally blind in two years, he was told.

A new research program at Penn Medicine is working to explore the underlying causes of abnormal uterine bleeding alongside a new mRNA treatment.

Researchers at the Perelman School of Medicine have tested types of messages that debunked vaccine misinformation with people considering getting vaccinated or boosted.